投資評等
最後更新日期：2024/11/23
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/7/9 | UBS | Neutral >> Buy | 48 |
| 2010/9/28 | ThinkEquity | Hold >> Buy | $12 >> $16 |
| 2006/5/24 | Banc of America Sec | Neutral Buy | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2010/11/2 | Canaccord Genuity | Buy >> Sell | $16 >> $10 |
| 2010/11/1 | Brean Murray | Hold >> Sell | 11 |
| 2010/9/14 | ThinkEquity | Buy >> Hold | $14 >> $12 |
| 2005/5/12 | McAdams,Wright,Ragen | Buy->Hold | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2011/3/9 | BioLogic Equity Research | Sell | |
| 2010/8/31 | ThinkEquity | Buy | 14 |
| 2010/8/4 | WBB Securities | Sell | 10.75 |
| 2010/3/19 | Brean Murray | Hold | |
| 2009/10/15 | Leerink Swann | Mkt Perform | 12 |
| 2009/8/12 | Deutsche Securities | Buy | 14 |
| 2005/11/29 | Banc of America Sec | Neutral | 1900/1/5 |
| 2005/10/17 | Needham Co | Buy | 1900/1/6 |
| 2005/7/21 | RBC Capital Mkts | Sector Perform | 8 |
| 2005/6/24 | Wells Fargo Sec | Hold | |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 查無資料 | | | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2011/5/6 | Needham | Buy | $18 >> $22 |
| 2011/1/21 | Oppenheimer | Outperform | $20 >> $18 |
| 2011/1/6 | ThinkEquity | Buy | $19 >> $20 |
| 2010/10/12 | RBC Capital Mkts | Outperform | $16 >> $20 |
| 2010/10/8 | ThinkEquity | Buy | $16 >> $19 |
| 2010/9/28 | UBS | Neutral | $12.50 >> $14.50 |
| 2010/9/14 | UBS | Neutral | $13 >> $12.50 |
| 2010/7/27 | Oppenheimer | Outperform | $13 >> $15 |
| 2010/4/13 | RBC Capital Mkts | Outperform | $12 >> $15 |
| 2004/3/9 | WR Hambrecht | Buy | 16 |